Ondansetron/Topiramate

昂丹司琼/托吡酯

Report date: 2022/07/01 15:47:42

Base Information

Drug NameOndansetron/Topiramate
Drug Alias NameOndansetron+Topiramate托吡酯+昂丹司琼托吡酯/昂丹司琼Topiramate+OndansetronTopiramate/Ondansetron +[6] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonistsGlutamate receptor ionotropic AMPA antagonistsCarbonic anhydrases inhibitors +[6] 
TargetsSerotonin 3 (5-HT3) receptorGlutamate receptor ionotropic AMPACarbonic anhydrases +[6] 
Therapy Area/IndicationsAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Ondansetron HydrochlorideTopiramate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdial Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdial Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAlcoholism

Other Information

ATC CodeN/A
Related LinksN/A